Cipla Medpro faces legal restrictions after the Cape Town High Court ruled that its trade name Furizome infringes on Adcock ...

SALT LAKE CITY (AP) Aaron Wiggins scored 35 points and Isaiah Joe added 32 on a career-high 10 3-pointers to lead the Oklahoma City Thunder to a 145-111 victory over the Utah Jazz on Friday night. ...

Cipla is currently trading at Rs 1463.90, showing a robust increase of 3.42% today. The 7-day exponential moving average at Rs 1495.45 suggests a positive trend in its recent performance. Cipla is ...

In the wake of US President Donald Trump's tariffs reaching 145 per cent, Chinese President Xi Jinping, in his first reaction, has called it 'unilateral bullying', urging Europe to stand with Beijing.

“All of them have 30 to 40% of their revenues coming from the US market,” he said. Companies like Dr Reddy’s Laboratories, Cipla, Sun Pharmaceutical Industries, and Aurobindo Pharma could see pressure ...

The United States on Thursday late night raised its tariffs on Chinese goods to a staggering 145%, marking the most aggressive trade escalation yet under President Donald Trump’s second-term trade ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and Drug ...

Cipla has secured USFDA approval to market a generic cancer treatment, specifically paclitaxel protein-bound particles. Equivalent to Bristol Myers Squibb's Abraxane, it treats various cancers and is ...

Mumbai: Cipla has announced that the Company has received final approval from the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (‘ANDA’) submitted for ...

Cipla share price: Pharmaceutical major Cipla shares were in demand on Friday, April 11, 2025, as the scrip popped up to 5.11 per cent to hit an intraday high of ₹1,488.80, upon securing USFDA ...

Shares of Cipla Ltd. opened with gains of as much as 5% on Friday, after the drugmaker announced that it has received final approval from the US Food and Drug Administration (USFDA) for its ...

Drug major Cipla on Friday said it has received approval from the US health regulator to market a generic cancer treatment drug. The company has received the final approval from the US Food and ...